21:35:34 EDT Tue 10 Mar 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

V:NRX - NurExone Biologic Inc. - https://www.nurexone.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NRX - V  2.00.58·0.612.00.58-0.02-3.367.537370.60  0.60  0.571.14  0.5515:59:59Feb 2715 min RT 2¢
TSX-V - V2.00.58·0.612.00.58-0.02-3.357.032240.60  0.60  0.571.14  0.5515:42:3515 min
NEO ATS - U 0.58-0.02-3.34.0220.58  0.58  0.5815:41:5915 min
Omega - O 0.57-0.03-5.02.0110.57  0.57  0.5715:25:4415 min
CX2 - H 0.58-0.02-3.34.0240.59  0.59  0.5715:59:5915 min
MatchNOW - M 0.600.506    15 min

Recent Trades - Last 10 of 37
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59H0.58-0.021,0001 Anonymous79 CIBCK
15:42:35V0.58-0.021,000124 Questrade1 AnonymousK
15:42:35V0.58-0.0221,500124 Questrade33 CanaccordK
15:41:59U0.58-0.021,50013 Instinet2 RBCK
15:41:59V0.58-0.022,50013 Instinet33 CanaccordK
15:30:30M0.57-0.0311 Anonymous80 National BankE
15:25:44H0.57-0.031,50079 CIBC1 AnonymousK
15:25:44O0.57-0.032,00019 Desjardins1 AnonymousK
15:25:44V0.57-0.0350079 CIBC1 AnonymousK
15:25:44V0.57-0.0350079 CIBC124 QuestradeK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-02-27 16:03C:NRX0.66News ReleaseNurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
2026-02-10 16:04C:NRX0.64News ReleaseNurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production
2026-01-30 17:29C:NRX0.66News ReleaseNurexone Biologic appoints Gabbai director
2025-12-19 16:04C:NRX0.69News ReleaseNurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
2025-12-12 17:02C:NRX0.61News ReleaseNurexone prepares small-scale manufacturing for ExoPTEN
2025-11-28 09:15C:NRX0.71News ReleaseNurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-26 17:18C:NRX0.71SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-26 17:12C:NRX0.71SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-12 22:03C:NRX0.70News ReleaseNurexone receives $3.18-million from warrant exercise
2025-11-04 02:56C:NRX0.69News ReleaseNurexone joins BioFab Startup Lab
2025-10-21 16:04C:NRX0.78News ReleaseNurExone Invited Presenter at Precision EV Forum in Cambridge, UK
2025-10-08 18:27C:NRX0.90News ReleaseNurexone shows vision recovery in glaucoma study
2025-09-17 20:52C:NRX1.07Private PlacementNurexone Biologic 930,376-share private placement
2025-09-17 04:55C:NRX1.05News ReleaseNurexone to open exosome production facility in Indiana
2025-09-12 01:22C:NRX0.90News ReleaseNurexone Biologic receives patent in Israel
2025-09-09 21:06C:NRX0.84Private PlacementNurexone Biologic 1,258,072-share private placement
2025-09-08 16:30C:NRX0.81News ReleaseNurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
2025-08-28 08:15C:NRX0.83News ReleaseNurExone Biologic Inc. Announces Second Quarter 2025 Financial Results
2025-08-20 19:36C:NRX0.79News ReleaseNurexone releases preclinical ExoPTEN imaging results
2025-08-08 17:30C:NRX0.69News ReleaseNurexone says exosomes beat industry healing standard